Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 14/20 | 0.63 |
| ▸ | PPARA | Q07869 | 13/20 | 0.63 |
| ▸ | PPARD | Q03181 | 4/20 | 0.60 |
| ▸ | MAOB | P27338 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.49 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 2/20 | 0.48 |
| ▸ | LAP3 | P28838 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6742509 | 0.90 | LTA4H (0.57) | PPARGPPARAPPARDMAOBFFAR1 | |
| SCHEMBL29919553 | 0.90 | LTA4H (0.57) | PPARGPPARAPPARDMAOBFFAR1 | |
| SCHEMBL6733991 | 0.89 | PPARA (0.56) | PPARGPPARAPPARDMAOBFFAR1 | |
| SCHEMBL1595266 | 0.88 | SRR (0.54) | PPARGPPARA | |
| SCHEMBL8823359 | 0.88 | SRR (0.54) | PPARGPPARA | |
| SCHEMBL6738478 | 0.88 | PPARG (0.51) | PPARGPPARAPPARDMAOBFFAR1 | |
| SCHEMBL6738771 | 0.87 | PPARG (0.69) | PPARGPPARAPPARDMAOBFFAR1 | |
| SCHEMBL25152974 | 0.84 | PPARG (0.47) | PPARGPPARAPPARDMAOBFFAR1 | |
| SCHEMBL6736991 | 0.83 | SLC7A5 (0.45) | PPARGPPARA | |
| SCHEMBL5607673 | 0.82 | PPARG (0.69) | PPARGPPARAPPARDMAOBFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040248849-A1 | 3-Aryl-A-oxy substituted propanoic acids and a process for their preparation | DR. REDDY'S LABORATORIES INC. | 2004-12-09 | — | — | US | claimed |
| WO-2003002575-A1 | 3-ARYL-$G(a)-OXY SUBSTITUTED PROPANOIC ACIDS AND A PROCESS FOR THEIR PREPARATION | DR. REDDY'S LABORATORIES LTD. (IN) | 2003-01-09 | — | — | WO | claimed |
| CN-117425644-A | Opioid receptor modulators | 埃皮欧黛公司 | 2024-01-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040248849-A1 | 3-Aryl-A-oxy substituted propanoic acids and a process for their preparation | GPR119, GLP1R, SLC5A1 | PPARG 124/4885PPARA 20/4885PPARD 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.